Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuqing Lou

Showing results (71-80 of 115) with videos related to

Pageof 12
Sort By:
Targeted Oncology|July 19, 2019
Correction to: Epidermal Growth Factor Receptor (EGFR)-Tyrosine Kinase Inhibitors (TKIs) Combined with Chemotherapy Delay Brain Metastasis in Patients with EGFR‑Mutant Lung AdenocarcinomaChanghui Li, Bo Zhang, Jindong Guo, et al.
Journal of Thoracic Disease|February 24, 2016
Factors that predict progression-free survival in Chinese lung adenocarcinoma patients treated with epidermal growth factor receptor tyrosine kinase inhibitorsShaohua Cui, Liwen Xiong, Yuqing Lou, et al.
Journal of Cardiothoracic Surgery|March 31, 2019
Prediction of lymph node status in completely resected IIIa/N2 small cell lung cancer: importance of subcarinal station metastasesRong Qiao, Runbo Zhong, Jianlin Xu, et al.
Targeted Oncology|July 5, 2019
Epidermal Growth Factor Receptor (EGFR)-Tyrosine Kinase Inhibitors (TKIs) Combined with Chemotherapy Delay Brain Metastasis in Patients with EGFR-Mutant Lung AdenocarcinomaChanghui Li, Bo Zhang, Jindong Guo, et al.
Journal of Cancer Research and Clinical Oncology|March 5, 2016
Efficacy of EGFR tyrosine kinase inhibitors for non-adenocarcinoma lung cancer patients harboring EGFR-sensitizing mutations in ChinaJianlin Xu, Yanwei Zhang, Bo Jin, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 12, 2016
Prophylactic Cranial Irradiation for Patients with Surgically Resected Small Cell Lung CancerJianlin Xu, Haitang Yang, Xiaolong Fu, et al.
Medical Oncology (Northwood, London, England)|March 23, 2015
Mitofusin-2 over-expresses and leads to dysregulation of cell cycle and cell invasion in lung adenocarcinomaYuqing Lou, Rong Li, Jielin Liu, et al.
Oncotarget|September 3, 2016
Two-stage induced differentiation of OCT4+/Nanog+ stem-like cells in lung adenocarcinomaRong Li, Jinsu Huang, Meili Ma, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|March 31, 2022
Equivalent efficacy assessment of QL1101 and bevacizumab in nonsquamous non-small cell lung cancer patients: A two-year follow-up data updateJun Lu, Tianqing Chu, Hongyu Liu, et al.
Plos One|April 13, 2011
Association study of the β2-adrenergic receptor gene polymorphisms and hypertension in the Northern Han ChineseYuqing Lou, Jielin Liu, Yao Li, et al.
Pageof 12

Showing results (71-80 of 115) with videos related to

Sort By:
Pageof 12
Targeted Oncology|July 19, 2019
Correction to: Epidermal Growth Factor Receptor (EGFR)-Tyrosine Kinase Inhibitors (TKIs) Combined with Chemotherapy Delay Brain Metastasis in Patients with EGFR‑Mutant Lung AdenocarcinomaChanghui Li, Bo Zhang, Jindong Guo, et al.
Journal of Thoracic Disease|February 24, 2016
Factors that predict progression-free survival in Chinese lung adenocarcinoma patients treated with epidermal growth factor receptor tyrosine kinase inhibitorsShaohua Cui, Liwen Xiong, Yuqing Lou, et al.
Journal of Cardiothoracic Surgery|March 31, 2019
Prediction of lymph node status in completely resected IIIa/N2 small cell lung cancer: importance of subcarinal station metastasesRong Qiao, Runbo Zhong, Jianlin Xu, et al.
Targeted Oncology|July 5, 2019
Epidermal Growth Factor Receptor (EGFR)-Tyrosine Kinase Inhibitors (TKIs) Combined with Chemotherapy Delay Brain Metastasis in Patients with EGFR-Mutant Lung AdenocarcinomaChanghui Li, Bo Zhang, Jindong Guo, et al.
Journal of Cancer Research and Clinical Oncology|March 5, 2016
Efficacy of EGFR tyrosine kinase inhibitors for non-adenocarcinoma lung cancer patients harboring EGFR-sensitizing mutations in ChinaJianlin Xu, Yanwei Zhang, Bo Jin, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 12, 2016
Prophylactic Cranial Irradiation for Patients with Surgically Resected Small Cell Lung CancerJianlin Xu, Haitang Yang, Xiaolong Fu, et al.
Medical Oncology (Northwood, London, England)|March 23, 2015
Mitofusin-2 over-expresses and leads to dysregulation of cell cycle and cell invasion in lung adenocarcinomaYuqing Lou, Rong Li, Jielin Liu, et al.
Oncotarget|September 3, 2016
Two-stage induced differentiation of OCT4+/Nanog+ stem-like cells in lung adenocarcinomaRong Li, Jinsu Huang, Meili Ma, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|March 31, 2022
Equivalent efficacy assessment of QL1101 and bevacizumab in nonsquamous non-small cell lung cancer patients: A two-year follow-up data updateJun Lu, Tianqing Chu, Hongyu Liu, et al.
Plos One|April 13, 2011
Association study of the β2-adrenergic receptor gene polymorphisms and hypertension in the Northern Han ChineseYuqing Lou, Jielin Liu, Yao Li, et al.
Pageof 12